NCT03231202 is a NA clinical trial of Embolization in Wounds and Injuries, sponsored by Oslo University Hospital.

Who is sponsoring NCT03231202?

NCT03231202 is sponsored by Oslo University Hospital.

What drugs are being tested in NCT03231202?

Interventions in NCT03231202: Embolization.

What condition does NCT03231202 study?

NCT03231202 studies Wounds and Injuries.

Is NCT03231202 still recruiting?

NCT03231202 is currently status unknown. Last updated 27 July 2017.

Last reviewed 2017-07-27 · How we verify

NCT03231202

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Splenic Injury Embolization - the Question About NOM (SInE Qua NOM)

Status unknown NA Last updated 27 July 2017

What this trial tests

NA trial testing Embolization in Wounds and Injuries in 224 participants. Status unknown.

Timeline

1 July 2017

Primary endpoint
1 August 2019

1 August 2019

Quick facts

Lead sponsor	Oslo University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	224
Start date	1 July 2017
Primary completion	1 August 2019
Estimated completion	1 August 2019
Sites	12 locations across Denmark, Netherlands, Sweden, United Kingdom, Germany, Norway, Canada, Australia

Drugs / interventions tested

Embolization

Conditions studied

Wounds and Injuries — all drugs for Wounds and Injuries →

Sponsor

Oslo University Hospital

Who can join

Adults 16 to 80, any sex, with Wounds and Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective is to compare the failure rate due to splenic bleeding between the patients undergoing pre-emptive splenic arterial embolization (SAE) as part of non-operative management (NOM) and the patients not undergoing SAE. We hypothesize that the use of pre-emptive SAE will decrease the delayed bleeding rate and increase the success rate of NOM.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Embolization

Trials testing the same drug.

NCT07494838 — IMAGES: Identifying Metabolic Imaging Association With Genicular Artery Embolization Success · NA · not yet recruiting
NCT06095050 — Embolization Treatment of Chronic Refractory Shoulder Tendinopathy · NA · recruiting
NCT05428735 — The DRAGON 2 Trial · NA · recruiting
NCT05714124 — Liver Embolization Approaches for Tumor Management · recruiting
NCT03884049 — Neovascularization Embolisation for Knee Osteoarthritis.(NEO) · NA · completed

Other recruiting trials for Wounds and Injuries

Currently open trials in the same condition.

NCT06921707 — Pilot Trial for WounDx™ Clinical Decision Support Tool · NA · recruiting
NCT06716411 — Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness · NA · recruiting
NCT05638581 — Trauma Resuscitation With Low-Titer Group O Whole Blood or Products · Phase 3 · recruiting
NCT05910567 — A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma · NA · recruiting
NCT06121661 — APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System · Phase 1 · recruiting

Other Oslo University Hospital trials

Trials by the same sponsor.

NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure · NA · not yet recruiting
NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure · not yet recruiting
NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study · recruiting
NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients · Phase 1 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03231202 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
Last refreshed: 27 July 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03231202.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing